nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life
|
Vedovato, Natascia |
|
|
67 |
5 |
p. 940-951 |
artikel |
2 |
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study
|
Slieker, Roderick C. |
|
|
67 |
5 |
p. 885-894 |
artikel |
3 |
Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease
|
Carrasquilla, Germán D. |
|
|
67 |
5 |
p. 864-873 |
artikel |
4 |
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank
|
Jin, Qiao |
|
|
67 |
5 |
p. 837-849 |
artikel |
5 |
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis
|
Jancev, Milena |
|
|
67 |
5 |
p. 798-810 |
artikel |
6 |
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research
|
Basset‑Sagarminaga, Jeremy |
|
|
67 |
5 |
p. 958 |
artikel |
7 |
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention
|
Pouwer, Frans |
|
|
67 |
5 |
p. 954-955 |
artikel |
8 |
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]
|
Ruissen, Merel M. |
|
|
67 |
5 |
p. 956-957 |
artikel |
9 |
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment
|
Su, Mengqi |
|
|
67 |
5 |
p. 850-863 |
artikel |
10 |
Feasibility of prevention of type 2 diabetes in low- and middle-income countries
|
Kengne, Andre P. |
|
|
67 |
5 |
p. 763-772 |
artikel |
11 |
Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study
|
Rauscher, Franziska G. |
|
|
67 |
5 |
p. 928-939 |
artikel |
12 |
Harnessing the power of proteomics in precision diabetes medicine
|
Kurgan, Nigel |
|
|
67 |
5 |
p. 783-797 |
artikel |
13 |
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes
|
Coomans de Brachène, Alexandra |
|
|
67 |
5 |
p. 908-927 |
artikel |
14 |
Keeping pace: the primary cilium as the conducting baton of the islet
|
Idevall-Hagren, Olof |
|
|
67 |
5 |
p. 773-782 |
artikel |
15 |
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study
|
Célind, Jimmy |
|
|
67 |
5 |
p. 874-884 |
artikel |
16 |
Metabolomic and genetic architecture of gestational diabetes subtypes
|
Lee, Kristen |
|
|
67 |
5 |
p. 895-907 |
artikel |
17 |
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
|
Cardoso, Pedro |
|
|
67 |
5 |
p. 822-836 |
artikel |
18 |
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial
|
Hyöty, Heikki |
|
|
67 |
5 |
p. 811-821 |
artikel |
19 |
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
|
Sánchez-Hernández, Rosa M. |
|
|
67 |
5 |
p. 952-953 |
artikel |
20 |
Up Front
|
|
|
|
67 |
5 |
p. 761-762 |
artikel |